Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Rituximab Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation - a Prospective Pilot Study

NCT01136395 is registered in ClinicalTrials.gov with University of Giessen as lead sponsor.

NCT NCT01136395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01136395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Rituximab Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation - a Prospective Pilot Study
Lead sponsor
University of Giessen
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2010
Completion date
June 18, 2019
Enrollment
85 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunology, kidney transplantation, living donors, rituximab (rtx), virus